An Australian-first study demonstrating the effectiveness of a new immunization against respiratory syncytial virus (RSV) for ...

With the RSV season officially underway in South Africa, experts are urging healthcare providers to prepare for an influx of ...

The bivalent respiratory syncytial virus prefusion F vaccine is highly effective and well tolerated against RSV-associated ...

Starting this spring, the Respiratory Syncytial Virus (RSV) vaccine will be available to adults aged 60 years and older residing in congregate living facilities, such as long-term care homes and ...

Early data suggests that the respiratory syncytial virus (RSV) vaccination programme is significantly reducing hospital admissions among ...

Historically, RSV has been studied mainly in infants and older adults, but recent research shows that it also poses a ...

The United Kingdom’s Health Security Agency (HSA) yesterday published it first annual report on infectious disease trends, ...

In primary care settings, the burden of RSV on young children and their guardians often varied between the countries of ...

You need to space out facial fillers when getting vaccines for the flu, Covid or RSV. Svitlana Hulko/Getty It’s flu season, ...

A single dose of respiratory syncytial virus vaccine was effective against infections and associated hospitalizations in veterans aged at least 60 years during the 2023-24 season.

Population-based analyses of new vaccination programmes provide robust real-world evidence for post-licensure vaccine ...